The association between insulin resistance and cytokines in adolescents: the role of weight status and exercise by Rubin, Daniela A. et al.
The association between insulin resistance and cytokines in
adolescents: the role of weight status and exercise
D.A. Rubin, R. G. McMurray, J.S. Harrell, A.C. Hackney, D.E. Thorpe, and A.M. Haqq
Department of Kinesiology (DAR), California State University Fullerton, Fullerton, CA, 92834,
Department of Exercise and Sport Science (D.A.R., R.G.M, A.C.H.), School of Nursing (J.S.H.),
School of Medicine, Department of Allied Health Sciences (D.A.R., R.G.M., A.C.H., D.E.T.),
University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599; Department of
Pediatrics (A.M.H.), Duke University Medical Center, Durham, North Carolina, 27710
Abstract
Increased adiposity is associated with insulin resistance (IR) and an inflammatory response in adults.
We tested the hypotheses that cytokines associated with adiposity are also correlated with IR in early
adolescents and that these relationships are moderated by weight status, levels of vigorous physical
activity (VPA), or maximal aerobic power (pVO2max). Body mass, stature, and a fasting blood
sample were obtained from 120 mid-pubertal adolescents (60 girls & 60 boys). Habitual VPA was
obtained by a survey. Predicted VO2max was determined using a cycle-ergometer test. Weight status
was based on body mass index percentiles (normal weight = BMI < 75th %tile and overweight = BMI
> 95th %tile). Glucose, insulin, adiponectin, resistin, tumor necrosis factor-α, and interleukin-6 were
measured, and IR index was based on the Homeostatic Model Assessment (HOMA). Adiponectin,
resistin and TNF-α were associated with IR in all adolescents (R2=0.329, p<0.001, R2=0.152,
p=0.001, R2=0.141, p=0.002; respectively), but IL-6 was not (R2=0.148, p=0.114). The degree of
association between adiponectin and IR was stronger in overweight than in normal weight
adolescents (p<0.050). When regression models included weight status, neither TNF-α nor resistin
were significantly related to IR (p>0.050). Exercise did not moderate the association between these
cytokines and IR. However, higher levels of VPA and/or pVO2max were associated with higher
adiponectin, lower resistin and lower TNF- α in at least one of the genders. Our results indicate that
the pathophysiology of obesity is already established in early adolescents. Increased adiposity,
resulting in reduced adiponectin and increased resistin and TNF-α may link these cytokines with
insulin resistance in adolescents.
1. Introduction
Increased adiposity has been strongly associated with insulin resistance in youth [1]. However,
the link between adipose tissue and the increased resistance to insulin is still unclear [2-3].
Cytokines released by the adipose tissue, such as adiponectin, resistin, interleukin-6 (IL-6),
and tumor necrosis factor-α (TNF-α), appear to link adiposity with insulin resistance in youth
[4-8], as in adults [3,10-15]. Adiponectin increases glucose uptake and free fatty acid oxidation
in skeletal muscle [16] and is associated with decreased insulin resistance in youth and adults
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[4,5,8,10]. The association between resistin and insulin resistance is equivocal [2,17]. Studies
in youth have not shown this association [18] and studies in adults presented contradictory
findings [11,19,20]. TNF-α and IL-6 act to inhibit insulin signaling in the adipose tissue [12,
21]. Although TNF-α and IL-6 have been associated with insulin resistance in adults [13-15],
there is little data in youth [6,9,15]. In pre-pubertal children there was no association between
TNF-α and insulin resistance [15], while in another group of children soluble TNF-α receptor
but not TNF-α was related to insulin resistance [6]. Similarly, IL-6 has been mostly related to
adiposity in youth and with the metabolic syndrome [7,9] but no clear link has been made
between insulin resistance and this cytokine in youth [9].
During puberty there is an increase in insulin resistance [22] that may be related to changes in
growth hormone, sex hormones and increases and redistribution of body fat [1]. All four of the
previously mentioned cytokines have been associated with body fat indicators in youth [4,5,
7-9,18]. Therefore, it could be expected that the strength of the association between cytokines
and insulin resistance is higher in overweight compared to normal weight youth. Similarly,
decreased physical activity levels and maximal aerobic power have been associated with
increased insulin resistance [23,24]. Levels of these cytokines appear to respond favorably to
chronic physical activity [25,26] and exercise training [27-29] in youth and in adults. It is
speculated that increased but not decreased physical activity or aerobic power, an indicator of
cardiovascular fitness, might attenuate, if existent, the relationship between insulin resistance
and resistin, TNF-α, and IL-6.
To our knowledge, this is the first study to explore associations between all four cytokines
(adiponectin, resistin, IL-6 and TNF-α) and insulin resistance in male and female adolescents,
and to examine the effect of weight status, physical activity levels, and aerobic power as
moderators of this association. Additionally, this study included a multiethnic (mostly bi-racial)
sample of adolescents in mid-puberty, the critical stage for a high degree of insulin resistance
and changes in body fat content. This study tested two hypotheses: (1) cytokines (adiponectin,
resistin, IL-6 and TNF-α) are associated with insulin resistance in mid-pubertal adolescents as
previously shown in adults, and (2) overweight status would have opposite moderating effects
than physical activity or aerobic power with regard to the associations between these cytokines
and insulin resistance.
2. Subjects and Methods
2.1. Subjects
Participants from the Cardiovascular Health in Children and Youth Study (CHIC III) between
the years 2000 and 2003 were the subjects for this cross-sectional study [30]. Sixty girls and
sixty boys, ages 10 to 14 years, who were mid pubertal (Tanner stages 2-4), were randomly
selected from sub-groups of 437 adolescents based on their weight status (normal weight versus
overweight) and levels of habitual vigorous physical activity (VPA). Half of the adolescents
selected were overweight (BMI>95th percentile using Centers for Disease Control and
Prevention [CDC] norms), and half had a normal weight (BMI<75th percentile using CDC
norms) [31]. Half of the adolescents also reported ≥180 min/week of habitual VPA (High-
VPA) while the others reported ≤120 min/week of habitual VPA (Low-VPA). The participants
signed an assent, and their parents or guardians signed an informed consent, approved by the
Institutional Review Board, that indicated their agreement to the use of the stored blood sample
for further analyses related to obesity.
2.2. Methods
Physical measures, habitual physical activity, pubertal status, a fasting blood sample, and
predicted maximal aerobic power (pVO2max) were obtained in the school setting by trained
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and certified research assistants. Measurements of stature and body mass were completed
within three days of blood sampling. The habitual physical activity survey and the pubertal
development questionnaire were completed in small groups under the supervision of a trained
research assistant.
All stature and body mass measurements were conducted with the subject dressed in shorts
and t-shirt, without shoes and with pockets emptied. Stature was measured to the nearest 0.1
cm using a stadiometer (Perspective Enterprises, Kalamazoo, MI) and body mass was obtained
to the nearest 0.1 kg using an electronic scale model 5602 (Scale-Tronix, Carol Stream, IL).
Body mass index (BMI) was computed dividing body mass in kg by stature in meters squared
(kg/m2). BMI was converted into a BMI percentile based on CDC norms for age and gender
[31]. Body mass index percentile was used to classify adolescents as normal weight or
overweight as previously indicated.
Pubertal developmental stage (Tanner stages 1-5) was assessed using a self-administered
survey. The items assessing physical development included growth spurt in height, pubic hair
and skin change (boys and girls), facial hair growth and voice change (boys), and breast
development and menarche (girls) [32]. Pubertal developmental stage was estimated (1-5)
based on a composite score derived from all the above mentioned survey items. This survey
has been correlated against physician ratings (r=0.61- 0.67) as well as self-ratings from Tanner
stage pictures (r=0.72- 0.80) [32].
Habitual VPA was obtained from a previously validated physical activity survey that had a
test-retest correlation coefficient of r= 0.70 [33]. The survey asked the youth to check how
often during a week they participated for at least 15 minutes in 32 activities common to North
Carolina youth. Frequency answers ranged from never to daily (scores 0-6). The intensities of
the 32 activities were determined using the Compendium of Physical Activity [34] and
expressed in metabolic equivalents (METs). One MET represents the average resting oxygen
consumption per kilogram body mass per min, e.g. 1 MET= 3.5 mL/kg/min. Only 9 of the
activities included in the survey were of vigorous intensity (METs ≥ 6). The VPA score was
calculated by summing the number of sessions per week for these 9 activities. Scores had a
possible range from 0 to 54 sessions per week. Adolescents who reported more than 12 sessions
per week of VPA were considered to have High-VPA, and those who reported less than 8
sessions per week were considered to have Low-VPA. This classification was based on the
results of a larger study on 437 adolescents (including this subgroup of 120 adolescents) that
showed that higher amounts of VPA were inversely related to insulin resistance, whereas
neither total habitual physical activity, nor moderate intensity activities (METs ≤ 3.8) were
associated with improved insulin resistance[24]. Peak aerobic power (pVO2max), an indicator
of cardiovascular fitness, was predicted from the previously validated PWC195 cycle ergometry
test which has been highly correlated (r=0.807) with maximal aerobic power [35].
Blood samples were obtained between 7-8 am after an overnight fast. Non-compliant
participants were not included. Samples were collected in EDTA-containing tubes and
immediately centrifuged at 4°C to obtain plasma. Plasma samples were kept on dry-ice during
transportation from the testing sites and were stored at −80°C until analyzed. Glucose was
determined using the hexokinase oxidase method which has a sensitivity of 1mg/dL (0.05551
mmol/L). Plasma insulin concentrations were determined by Linco Laboratories (St. Charles,
MO) with a coefficient of variation (CV) of 8.0%. Plasma adiponectin, resistin, TNF-α, and
IL-6 were obtained from enzyme immunoassay procedures. Adiponectin and resistin were
assayed utilizing kits from Linco Research Inc. (St.Charles, MO). The adiponectin assay had
a limit of sensitivity of 0.78 ng/mL with intra and inter-assay CVs of <10% and 11.6%,
respectively. The resistin assay had a sensitivity of 0.5 ng/mL, with intra and inter-assay CVs
of <10% and 11.2%, respectively. TNF-α and IL-6 were assessed utilizing kits from R & D
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Systems (Minneapolis, MN). The TNF-α kit had a sensitivity of 0.5 pg/ml, while the IL-6 kit
had a sensitivity of 0.2 pg/ml. The intra-assay CV for TNF-α and IL- 6 assays was <10%. The
inter-assay CV for TNF-α was 12.2% and for IL- 6 was 18.2 %. Insulin resistance was assessed
using the Homeostatic Model Assessment for insulin resistance (HOMA) [36].HOMA has
been validated in children and adolescents [37] and was computed as follows: HOMA= insulin
[μIU/mL] × glucose [mmol/L]/22.5.
2.3. Statistical analysis
Mean and standard deviation values were computed for all variables for all subjects in the
study. Frequency tables were generated to determine the number of Caucasian, African
American and “other” youth. Other ethnicities included: Asian, Native and other. Separate
analyses of variance were conducted for the physical characteristics, metabolic factors, and
exercise variables to determine differences between the genders and ethnic groups. A Mann-
Whitney test was used to determine differences in pubertal status between the genders and
between African American and Caucasian youth.
Cytokines, insulin, glucose and HOMA values were transformed using the natural logarithm
for all the regression analyses, because these variables were not normally distributed.
Exploratory Pearson product correlations were computed to determine associations among
HOMA, cytokines, BMI, and pVO2max. Because VPA was dichotomized into two groups,
Spearman Rho correlations were computed between this variable, HOMA, and the cytokines.
To determine if the cytokines were associated with insulin resistance, five multiple regression
models were computed for each cytokine using the “enter” method of regression analysis. This
method evaluates the significance of the relationship of every variable in the model when
entered all together. The first model included only the cytokine controlling for gender and
ethnicity. The second, third, and fourth models tested the moderator effect of weight status,
VPA, and pVO2max respectively. Thus, the second model tested if the relationship between
the cytokine and insulin resistance was different depending on the weight status (normal weight
vs. overweight). The third model tested if the relationship between the cytokine and insulin
resistance was different depending on the levels of VPA (High vs. Low). The fourth model
tested if the relationship between the cytokine and insulin resistance was different depending
on the levels of VO2max. Significant parameters from models 2-4 were used to test a final
model. The interaction terms (cytokine * weight status, cytokine * VPA, and cytokine *
VO2max) were included because weight status, VPA, and pVO2max may moderate the
association between the cytokines and insulin resistance [11,7-8,25-29]. Statistical significance
was set at p<0.05. Analyses were conducted utilizing Statistical Package for the Social Sciences
(SPSS) version 9.0 for Windows (Chicago, IL).
3. Results
The characteristics of the subjects are presented in Table 1. Racial distribution was 57%
African-American, 37% Caucasian, and 6% other ethnic groups. There were 60 girls and 60
boys participating in this study. The distribution of normal and overweight adolescents in the
sample was the same, and the number of adolescents reporting high VPA or low VPA was
equal.
African American youth were heavier and had higher BMI than Caucasian youth (p<0.050).
African American youth also had lower adiponectin (p=0.029), higher resistin concentrations
(p=0.029), and higher HOMA (p=0.002) than Caucasian youth. There were no differences in
puberty between both groups (p=0.226) Lastly, African American youth had higher VPA scores
than Caucasian (p=0.007). There were no statistically significant group differences between
the genders for age, race, stature, body mass, BMI, cytokines, HOMA, or VPA (p>0.050 for
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all). The girls were at higher mean pubertal stage than the boys (p<0.050) and the boys had
higher pVO2max than the girls (p<0.050).
The univariate correlations indicated that HOMA was significantly negatively associated with
adiponectin in the boys and in the girls (r=-0.628 and r=-0.438, p<0.008, respectively) and
significantly positively associated with resistin in the boys only (r=0.291, p=0.024). HOMA
was not associated with either TNF-α, or IL-6 in either gender. Body mass index was associated
with adiponectin in both girls and boys (r=-0.469, r=-0.610; p<0.001, respectively), and with
IL-6 in the girls (r=0.329; p=0.01) but not the boys. Positive trends were obtained between
BMI and resistin (r=0.201), or IL-6 (r=0.244) in boys. VPA was associated only with
adiponectin in the girls (r=0.306, p=0.017), and with resistin in the boys (r=-0.286, p=0.027).
Peak VO2max was associated with adiponectin in the girls and in the boys (r=0.337, r=0.351;
p<0.05, respectively), with resistin in the boys (r=-0.374; p<0.05), and with TNF- α in the girls
(r=-0.314; p<0.05) (Fig. 1).
Table 2 presents select results of the five multiple regression models in which HOMA was
regressed separately with each cytokine (adiponectin, resistin, TNF-α, or IL-6). Only model
1, significant models that contained interaction terms, and the final models are presented in the
Table. Adiponectin was negatively associated with HOMA (Model 1, p<0.001 for β-
coefficient) and weight status significantly moderated the relationship between adiponectin
and HOMA (Model 2, p=0.047 for β-coefficient) (Fig. 2). Neither VPA nor pVO2max
moderated the relationship between adiponectin and HOMA (Models 3 and 4, p>0.05 for
interaction β-coefficients) but pVO2max was a significant predictor of HOMA (Model 4
p=0.036 for β-coefficient). Moreover, when pVO2max was included in the final model, weight
status did not moderate the relationship between adiponectin and HOMA (Final Model p=0.080
for interaction β-coefficient)
Resistin was weakly associated with HOMA (Model 1, R2= 0.152; p=0.001). Weight status
did not interact between HOMA and resistin (Model 2, p>0.05 for β-coefficient) but was a
significant predictor of HOMA (p=0.006 for β-coefficient). VPA moderated the association
between resistin and HOMA (Model 3, p=0.028 for β-coefficient). Predicted VO2 max did not
interact between resistin and HOMA (Model 4, p>0.05 for β-coefficient), but was significantly
associated with HOMA (p=0.010). In the final model, weight status was associated with
HOMA, and VPA interacted in the association between resistin and HOMA (p<0.05 for all).
TNF-α was weakly associated with HOMA (R2= 0.141; p=0.002). Although weight status did
not directly moderate the association between TNF-α and HOMA (Model 2, p=0.233 for
interaction β-coefficient) when included in the model, the association between TNF-α and
HOMA was no longer significant (p=0.231 for TNF- α β-coefficient). Neither VPA nor
pVO2max interacted in the association between TNF-α and HOMA (Models 3 and 4, p>0.05
for both interactions β-coefficients), but pVO2max was a significant predictor of HOMA
(Model 4, p<0.001 for β-coefficient). Interleukin-6 was not a significant predictor of HOMA
(p=0.114 for β-coefficient).
4. Discussion
Insulin resistance, cytokines and weight status
We chose to examine the association between selected cytokines and insulin resistance in
adolescents. The selected four cytokines were studied because of existing data in adults
suggesting such associations existed [10,11,12-14]. Although many studies have demonstrated
a negative association between adiponectin and insulin resistance [4-5,9], we hypothesized a
different association between adiponectin and insulin resistance depending on weight status.
We showed that in overweight adolescents, an increase of log-adiponectin by 1 unit predicted
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a 45.1% decrease in the log HOMA. However, in the normal weight adolescents, a 1 unit change
moderated the HOMA by 2 %. This finding suggests that the protective role of adiponectin on
insulin resistance is more relevant in overweight youth. Weiss et al. showed a similar
relationship in moderately obese adolescents, but not in severely obese adolescents [38]. We
speculate that in normal weight adolescents, the concentrations of adiponectin, other cytokines,
triglycerides, and leptin are normal, and therefore, the protective role of adiponectin is minimal.
Once adiposity levels increase further, as in severely obese youth, adiponectin’s protective role
might be superseded by the other mentioned adipokines. The moderator effect of weight status
in this association was also not relevant when aerobic power was included in the model; perhaps
because of the inclusion of body mass in aerobic power units.
One of our novel findings was that resistin was related to HOMA in our adolescent population.
In adults, Silha et al. [11] have shown similar results to ours; yet other studies have failed to
show this association [18,19]. In contrast to our results, Gerber and colleagues failed to show
a relationship between insulin resistance indicators and resistin in youth, possibly because of
their study’s low statistical power [18]. Our results suggest that insulin resistance is weakly
associated with resistin; however this association may be dependent on the association between
adiposity and resistin, as shown in adults [20].
Contrasting the results obtained in children [6-8,15] TNF-α, was associated with HOMA in
the adolescents of the present study. Others have shown an association between soluble TNF-
α receptor 2 and insulin resistance, but not TNF-α [6]. Our results should be interpreted with
caution, since the regression model only explained 14.1% of the variance in HOMA. Moreover,
when weight status was considered, TNF-α did not explain a significant variance in HOMA.
The importance of TNF-α in the development of insulin resistance may become more evident
as youth age [15], as different factors contribute to the development of this insulin resistant
state [39].
We found no association between IL-6 concentrations and HOMA regardless of weight status.
Similarly, Nemet et al. showed no correlation between IL-6 and fasting insulin [9]. Weiss et
al. showed no differences in the concentrations of IL-6 across categories of insulin resistance
in a large sample of obese children and adolescents [38]; though Kelly and associates presented
a positive trend in IL-6 in youth with metabolic syndrome [7]. The development of insulin
resistance is multifactorial in origin; possibly, IL-6 becomes a more important player as
adolescents age, because its effects may become additive to the effects of other increased
cytokines, such as TNF-α, Interleukin-1β and leptin [39]. The combination of elevated
inflammatory and atherogenic cytokines present in youth with metabolic syndrome [7] would
support this previous speculation.
Exercise as a moderator of the relationship between IR and cytokines
In the resistin model, HOMA was negatively associated with habitual VPA suggesting that
more sessions per week of VPA are associated with lower insulin resistance. However, VPA
interacted in the association between resistin and HOMA in the opposite way of what we
anticipated. Specifically, a 1 unit increase in the natural log of resistin predicted a 59.2%
increase in the natural log of HOMA in those adolescents who had high VPA. In contrast, an
increase of 1 unit in the natural log of resistin predicted an 11 % decrease in the natural log of
HOMA in those adolescents who had low VPA. Neither weight status, overall adiposity as
indicated by BMI, puberty, nor ethnicity explained this association. Therefore, further research
is necessary to explore the effect of exercise in the relationship between resistin and insulin
resistance.
In contrast with what we hypothesized, neither habitual VPA nor pVO2max moderated the
association between insulin resistance and adiponectin or TNF-α. Although pVO2max was
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associated with HOMA in most of the regression models, pVO2max was not significant when
weight status was included in the model for resistin. This could be because of the inclusion of
body mass in the units of aerobic power as well as in BMI (kg/m2). Findings in adults [26,
27,28] led us to hypothesize that the inclusion of exercise in our models would strengthen the
association between adiponectin and HOMA, and would weaken all the other associations. In
obese youth, increasing the levels of physical activity resulted in decreased insulin resistance
and IL-6 concentrations [29]. Supporting our speculations, a recently published study in
adolescents showed increased circulating adiponectin, and decreased TNF- α in physically
active versus sedentary girls [25]. In the present study we show that increased sessions perweek
of physical activity in adolescence can be associated with higher adiponectin concentrations
in the girls and lower resistin concentrations in the boys. In contrast to Nemet et al. [9] aerobic
power was negatively associated with lower TNF- α. The difference in the findings between
Nemet et al. and ours can be explained by the different units used to express aerobic power
(mL/min vs. mL/kg/min).
Our findings mirrored previous results related to adiponectin and insulin resistance [6,8,17]
and expanded previous studies’ findings by including other cytokines of interest and other
relationships. However, our findings present some methodological limitations. VPA was self-
reported and there could be recall bias in this measurement. We used the Compendium of
Physical Activities to determine the intensity of physical activity as others have done [25] but
this compendium is based on data from adults [34]. The use of a more sensitive measure of
insulin resistance might have strengthened the relationships between the cytokines and insulin
resistance. However, the HOMA (derived from a mathematical model) has been shown to be
an adequate indicator of insulin resistance in youth [37] and to be associated with VPA and
pVO2max [24]. Lastly, cytokines as well as hormones can be acutely modified by previous
physical activity or exercise [40] limiting our cytokine results.
Conclusion
Our results show that, in adolescents, insulin resistance is related to decreased adiponectin,
increased resistin and TNF-α. The link between these cytokines and insulin resistance is
probably related to increased adiposity mostly in overweight youth. Habitual VPA and
pVO2max do not appear to have a strong influence on the relationships between these cytokines
and insulin resistance in either normal or overweight youth. But this is not to say that higher
amounts of physical activity [23-26] or exercise interventions [27-29] would not improve
insulin resistance or these cytokines. Moreover, our results show that higher levels of habitual
VPA and pVO2max are correlated with increased adiponectin and decreased resistin, both
somewhat protective against insulin resistance. Similarly, the present results support the
negative association between insulin resistance and increased aerobic power and physical
activity previously shown [23,24].
Although our findings present methodological and statistical limitations as the degree of the
associations is moderate to low, they suggest that increased levels of adiposity, resulting in
decreased adiponectin, increased resistin and TNF-α concentrations, may link being
overweight with insulin resistance during adolescence. Thus, the inflammatory condition that
appears to link obesity with insulin resistance in adulthood [2,3] is also present during puberty.
The efforts to reduce insulin resistance in adolescents should focus on body fat mass loss and
prevention of body fat mass gain through increased physical activity, improved aerobic power,
and a healthy diet.
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Scatterplots presenting significant associations between cytokines, HOMA, BMI, and exercise.
Filled circles are used for girls’ data and open circles are used for boys’ data.
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Scatterplot presenting the moderatoreffect of weight status (normal weight vs. overweight) in
the association between adiponectin and insulin resistance. Open triangles are used for
overweight adolescents’ data, and filled triangles are used for normal weight adolescents’ data.
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